Launched earlier this year for people with type 1 diabetes, the company estimates the agency’s green light adds about 5.5 million people in the U.S. who manage their condition with insulin.
Available through pharmacies with a prescription, the twiist carries a 300-unit insulin reservoir and is compatible with continuous glucose monitors including Abbott’s FreeStyle Libre 3 Plus and Senseonics’ Eversense 365.
The device also carries onboard sensors to ensure accurate dose delivery and identify blockages, and continuously adjusts basal insulin levels through an algorithm based on the Tidepool Loop.
Get the full story at our sister site, Drug Delivery Business News
